ReP USP - Resultado da busca

Artigo de periodico
Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: insights from the TIGRIS registry (2022)
Russo, Juan J; Yan, Andrew T; Pocock, Stuart J; Brieger, David; Owen, Ruth; Sundell, Karolina Andersson; Bagai, Akshay; Granger, Christopher B; Cohen, Mauricio G; Nicolau, Jose Carlos
Source: Journal of cardiology. Unidade: FM
Subjects: VASOS CORONÁRIOS, INFARTO DO MIOCÁRDIO, FÁRMACOS SINTÉTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUSSO, Juan J et al. Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: insights from the TIGRIS registry. Journal of cardiology, v. 79, n. 4, p. 522-529, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jjcc.2021.10.024. Acesso em: 31 out. 2024.
APA
Russo, J. J., Yan, A. T., Pocock, S. J., Brieger, D., Owen, R., Sundell, K. A., et al. (2022). Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: insights from the TIGRIS registry. Journal of cardiology, 79( 4), 522-529. doi:10.1016/j.jjcc.2021.10.024
NLM
Russo JJ, Yan AT, Pocock SJ, Brieger D, Owen R, Sundell KA, Bagai A, Granger CB, Cohen MG, Nicolau JC. Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: insights from the TIGRIS registry [Internet]. Journal of cardiology. 2022 ; 79( 4): 522-529.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.jjcc.2021.10.024
Vancouver
Russo JJ, Yan AT, Pocock SJ, Brieger D, Owen R, Sundell KA, Bagai A, Granger CB, Cohen MG, Nicolau JC. Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: insights from the TIGRIS registry [Internet]. Journal of cardiology. 2022 ; 79( 4): 522-529.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.jjcc.2021.10.024
Artigo de periodico
Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry (2020)
Pocock, Stuart J; Brieger, David; Gregson, John; Chen, Ji Y; Cohen, Mauricio G; Goodman, Shaun G; Granger, Christopher B; Grieve, Richard; Nicolau, José Carlos ; Simon, Tabassome
Source: Clinical cardiology. Unidade: FM
Subjects: INFARTO DO MIOCÁRDIO, DOENÇAS CARDIOVASCULARES, FATORES DE RISCO, INCIDÊNCIA, ANÁLISE DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
POCOCK, Stuart J et al. Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry. Clinical cardiology, v. 43, n. 1, p. 24-32, 2020Tradução . . Disponível em: https://doi.org/10.1002/clc.23283. Acesso em: 31 out. 2024.
APA
Pocock, S. J., Brieger, D., Gregson, J., Chen, J. Y., Cohen, M. G., Goodman, S. G., et al. (2020). Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry. Clinical cardiology, 43( 1), 24-32. doi:10.1002/clc.23283
NLM
Pocock SJ, Brieger D, Gregson J, Chen JY, Cohen MG, Goodman SG, Granger CB, Grieve R, Nicolau JC, Simon T. Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry [Internet]. Clinical cardiology. 2020 ; 43( 1): 24-32.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/clc.23283
Vancouver
Pocock SJ, Brieger D, Gregson J, Chen JY, Cohen MG, Goodman SG, Granger CB, Grieve R, Nicolau JC, Simon T. Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry [Internet]. Clinical cardiology. 2020 ; 43( 1): 24-32.[citado 2024 out. 31 ] Available from: https://doi.org/10.1002/clc.23283
Artigo de periodico
Cardiovascular and renal outcomes with empagliflozin in heart failure (2020)
Packer, Milton; Anker, Stefan D; Butler, Javed; Filippatos, Gerasimos; Pocock, Stuart J; Carson, Peter; Januzzi, James; Verma, Subodh; Tsutsui, Hiroyuki; Bocchi, Edimar Alcides
Source: New england journal of medicine. Unidade: FM
Subjects: ENVELHECIMENTO, DOENÇAS CARDIOVASCULARES, MORTALIDADE, PREVENÇÃO E CONTROLE, INSUFICIÊNCIA CARDÍACA, FISIOPATOLOGIA, INSUFICIÊNCIA RENAL CRÔNICA, HOSPITALIZAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PACKER, Milton et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. New england journal of medicine, v. 383, n. 15, p. 1413-1424, 2020Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa2022190. Acesso em: 31 out. 2024.
APA
Packer, M., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Carson, P., et al. (2020). Cardiovascular and renal outcomes with empagliflozin in heart failure. New england journal of medicine, 383( 15), 1413-1424. doi:10.1056/NEJMoa2022190
NLM
Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Bocchi EA. Cardiovascular and renal outcomes with empagliflozin in heart failure [Internet]. New england journal of medicine. 2020 ; 383( 15): 1413-1424.[citado 2024 out. 31 ] Available from: https://doi.org/10.1056/NEJMoa2022190
Vancouver
Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Bocchi EA. Cardiovascular and renal outcomes with empagliflozin in heart failure [Internet]. New england journal of medicine. 2020 ; 383( 15): 1413-1424.[citado 2024 out. 31 ] Available from: https://doi.org/10.1056/NEJMoa2022190

USP Schools

ReP

Filtros

Authors

Subjects